When it comes to making equity improvements and successes sustainable, leadership from the top levels are required, and that means finding champions who are bold, open to collaboration, and willing to explore new partnerships with an open mind, the panel agreed.
A patient advocate, an entrepreneur, and representatives from pharma and a pharmacy benefit manager shared how their organizations are working to identify medication use quality disparities during a panel at the Pharmacy Quality Alliance 2022 Annual Meeting this week in Baltimore, Maryland.
The session, which was moderated by Melissa Castora-Binkley, PhD, PQA’ s senior director of research, also delved into issues around leadership, culture, and trust. Panelists included:
Castora-Binkley asked for examples of how organizations are working to identify and prioritize disparities, as well as addressing any unintended consequences that might arise as a result of such findings.
At CVS Health, Travis said disparities in heart health between Black and White Americans are a focus for the company overall, as well as the company’s new chief health equity officer, Joneigh Khaldun, MD, MPH, FACEP who was previously Michigan’s chief medical executive and chief deputy director of health for the state’s Department of Health and Human Services.
Mitchell, who before forming her own firm was a vice president at Avalere, cited a few potential unintended consequences of examining disparities. In one, she described a multiyear project developing performance measures for CMS around heart failure, heart attacks, and hypertension. Despite the fact that thousands of measures were developed, only a small subset were used and an even small number dealt with accountability. In volume-driven programs, despite data showing where the gaps are, there might never be follow up.
In another potential example, the information gathered on certain vulnerable populations or regarding certain local areas through the use of artificial intelligence and advanced data analytics has the potential to negatively impact decision-making.
“Can we risk adjust them out?" Mitchell posited. "It sounds sneaky, but guess what, it can happen.”
And implementing social determinant of health screening tools without the right education can worsen the high levels of distrust that marginalized communities already have towards the medical profession.
If a patient is “so inclined to answer whether or not I'm food insecure and then you provide no direction to resources for me to actually close that gap, you've done nothing but increase the level of distrust and mistrust around me giving you that information,” she pointed out.
Balch agreed about not inadvertently creating situations that cause a patient to be more distrusting of health care. “I think the solution part is to introduce these ideas and conversations really, into a person's health care experience, not just waiting until it's a problem.”
People want to feel respected and listened to, and to feel like the care they received was personalized.
Castora-Binkley asked for examples of how the concept of health equity can be made actionable and practical.
“It's something that you need to drive across every service line, business line,” Balch said. “And that means focusing not just on what you're doing, but how you're doing it, and what's happening within your own building, and how are you addressing all that? Disparities within your own workforce, within your board, within your staff.”
When it comes to making equity improvements and successes sustainable, leadership from the top levels are required, and that means finding champions who are bold, open to collaboration, and willing to explore new partnerships with an open mind, the panel agreed.
As organizations find successes—or “wins”— in this area, continually tying these to organizational values will help embed the process and make it authentic, Ryan said. “It's not just we're doing it because it's good to do, right? We're doing it because it's good for us… So then, it becomes more of a ongoing sustaining WIIFM [what’s in it for me] activity,” he said.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More